Circuit

• AUSTIN, Texas, May 22, 2023 (GLOBE NEWSWIRE) -- Gotransverse ( www.gotransverse.com ), the leading provider of enterprise order-to-cash solutions, today announced that the company is ranked as one of the 2023 Best Places to Work by the Austin Business Journal.
• Every year, the Austin Business Journal recognizes companies that support their employees with professional development and other rewards.
• Winners named to the Best Places to Work list are selected using anonymous surveys which gauge employee satisfaction in key areas such as leadership and communications.
• "Austin has one of the country's most competitive and diverse job markets, and ranking as one of the Best Places to Work helps us attract and retain the best talent,” said James Messer, founder and CEO of Gotransverse.

• LANHAM, Md., May 12, 2023 /PRNewswire/ -- edX , a leading global online learning platform from 2U, Inc. (Nasdaq: TWOU), today announced the debut of two AI-powered innovations: the new edX plugin for ChatGPT and edX Xpert, an AI-powered learning assistant on the edX platform.
• The edX ChatGPT plugin is part of the initial wave of plugins available for ChatGPT Plus users.
• Also debuting today is edX Xpert, an AI-powered learning assistant embedded in the edX platform.
• This allows learners to quickly identify relevant content for learning, reviewing, or reinforcing concepts, helping to maximize the time they spend learning on the platform.

• Toyota Racing Development (TRD) is pleased to announce an official partnership with Segra, one of the largest independent fiber infrastructure bandwidth companies in the Eastern U.S. With over a century of helping customers achieve connectivity, Segra has been named as the Official IT Infrastructure Partner of TRD, along with receiving official status in Toyota’s single-make series, the GR Cup.
• “We are honored to have been chosen as the Official IT Infrastructure Partner for Toyota Racing Development,” says Kevin T. Hart, CEO of Segra.
• Segra joins a wide ranging list of official TRD partners, including ExxonMobil, HARMAN Automotive, Safelite AutoGlass, Apex Tool Group, Yahoo, Stratasys, GF Machining Solutions and Racing Force Group.
• “We are pleased to announce this official relationship with Segra,” said David Wilson, president, TRD.

• The decision is temporary, however, buying time as an appeals court weighs the challenge to mifepristone brought by a Texas judge in early April 2023.
• That ruling blocked the use of the drug in medication abortions and sought to remove it from the market altogether, questioning its safety.
• Days later, a U.S. appeals court reversed the suspension on mifepristone but placed tighter restrictions on it, including preventing it from being sent through the mail.

1. What led up to the Supreme Court’s ruling on mifepristone?

• The doctors brought the case in Texas, where a federal district judge ordered that, while the case was pending, mifepristone should be off the market.
• The FDA appealed to the 5th Circuit, asking it for an emergency “stay,” or a hold on, the district court’s order.
• The FDA, along with mifepristone’s manufacturer Danco Laboratories, immediately asked the Supreme Court to stay the 5th Circuit’s order.

2. What comes next in the courts?

• The Supreme Court’s decision means that mifepristone will remain available until there is a final decision in this case.
• Depending on the outcome of that case, either the plaintiffs or the defendants may ask the Supreme Court to hear the case.
• If the Supreme Court decides to hear the case, then the final decision on whether mifepristone should be taken off the market or have stricter requirements for use will come from the Supreme Court.

3. What does this mean for abortion access moving forward?

• The Supreme Court’s decision to preserve full access to mifepristone until the case concludes leaves the FDA’s current rules in place.
• Misoprostol, which is approved for use in the treatment of gastric ulcers, also causes uterine contractions and ends the pregnancy.
• These procedures would exacerbate harms to those electing or experiencing abortion, including risks to subsequent pregnancies.
• Even Supreme Court justices ambivalent about legal rights to abortion have expressed a desire for abortions to occur as early as possible.

4. What are the implications for other medications?

• The FDA did review multiple studies that showed lifting these individual restrictions was indeed safe for those taking mifepristone.
• Second-guessing the agency’s scientific determination in this way challenges the nuts and bolts of the FDA’s process and certainty in the drug manufacturing market.
• This is particularly true for medicine that may have higher risks but can be lifesaving for patients.
• Leaders from across the scientific, pharmacologic and business world have sounded the alarm at the implications of these decisions on approved drugs and those in development.